You searched for Parkinson's - Page 15 of 19

News and Trends 6 Jun 2022

Mitochondria in focus as 4BIO Capital co-leads $30.3M financing in LUCA Science

…is working in the field of mitochondrial biology to treat Parkinson’s, motor neuron disease and other neurodegenerative disorders, received a $5.8M Biomedical Catalyst (BMC) award to fund preclinical development of…

June 6, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 22 Sep 2022

Research identifies new treatment target for CNS injury and neurological disease

…Optic nerve damage was of interest to the researchers because it occurs in patients with glaucoma, multiple sclerosis, Alzheimer’s and Parkinson’s disease. Here the animal models showed that administration of…

September 22, 2022 - 3 minutesmins - By Jim Cornall

Best in Biotech 18 Apr 2024

5 RNA editing companies you should know about

…innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer’s, Parkinson’s, and many more. In August 2021, Shape…

April 18, 2024 - 7 minutesmins - By Willow Shah-Neville

News and Trends 11 Apr 2023

PsychoGenics launches eCube AI platform for drug discovery

…research in areas such as Huntington’s disease, autism spectrum disorders, psychosis/schizophrenia, depression, PTSD, Alzheimer’s disease, Parkinson’s disease, muscular dystrophy, ALS and seizure disorders. PsychoGenics featured recently in Labiotech’s feature on…

April 11, 2023 - 3 minutesmins - By Jim Cornall

Best in Biotech 22 Jul 2025

Seven biotechs in Belgium making leaps in the clinic

…The biopharma is also engaged in the discovery of drugs for Parkinson’s disease, type 1 diabetes, and an autoimmune disease called spondyloarthritis that affects the spine and the joints. Precirix …

July 22, 2025 - 11 minutesmins - By Roohi Mariam Peter

In Depth 27 Jun 2025

Psychedelics sans side effects: neuroplastogens gain ground

…essential for neurodegenerative diseases including Alzheimer’s and Parkinson’s,” said Missling. In a phase 2b/3 trial, early and late start treatment groups were compared. Those who were on blarcamesine earlier in…

June 27, 2025 - 8 minutesmins - By Roohi Mariam Peter

News and Trends 17 Sep 2021

Cell Therapy Firm Raises €64M to Revolutionize Manufacturing

…and at a better quality than current cell therapy manufacturing techniques. TreeFrog is also developing its own cell therapy candidates, starting with a Parkinson’s disease therapy due to enter phase…

September 17, 2021 - 8 minutesmins - By Helen Albert

In Depth 12 Jul 2023

Medicon Valley: how the initiative shaped biotech ecosystems in Denmark and Sweden

…to lowering the risk of Parkinson’s and other neurodegenerative diseases. The organization’s Microbiome Network enables members to collaborate on drug discovery, nutrition and probiotic development. A prominent player in the…

July 12, 2023 - 10 minutesmins - By Roohi Mariam Peter

In Depth 25 Jan 2024

The trends that will shape the biotech industry in 2024

…and extend research and development timelines. Furthermore, the use of stem cell technologies for purposes like drug testing, disease simulation, and the treatment of neurodegenerative diseases, such as Parkinson’s and…

January 25, 2024 - 13 minutesmins - By Jules Adam

Best in Biotech 21 May 2024

Eight companies spearheading Philadelphia’s biotech industry

…a T-regulatory (Treg) candidate focused on lung cancer targeting the FOXP3 gene. AUM LifeTech also develops a project targeting Parkinson’s disease. BlueWhale Bio BlueWhale Bio, a biotech company founded in…

May 21, 2024 - 10 minutesmins - By Jules Adam

News and Trends 7 Jun 2022

Yumanity selling neurology assets and merging with Kineta

…placed a partial clinical hold on multidose clinical trials of YTX-7739, currently being developed for the treatment of Parkinson’s disease. The FDA did not stop all clinical programming and allowed…

June 7, 2022 - 3 minutesmins - By Jim Cornall

Best in Biotech 31 Dec 2018

European Biotech’s Biggest News of 2018

…Lundbeck paying up to €900M in March for the Swiss biotech Prexton Therapeutics, which is developing a drug for Parkinson’s disease. Then there were the big deals and collaborations. Genentech…

December 31, 2018 - 12 minutesmins - By Jonathan Smith

Knowledge hub

Categories

Webinar: Organoids in cancer research - Paving the way for faster drug development across cancer indications

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Webinar: Organoids in cancer research - Paving the way for faster drug development across cancer indications

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Parkinson's

Mitochondria in focus as 4BIO Capital co-leads $30.3M financing in LUCA Science

Research identifies new treatment target for CNS injury and neurological disease

5 RNA editing companies you should know about

PsychoGenics launches eCube AI platform for drug discovery

Seven biotechs in Belgium making leaps in the clinic

Psychedelics sans side effects: neuroplastogens gain ground

Cell Therapy Firm Raises €64M to Revolutionize Manufacturing

Medicon Valley: how the initiative shaped biotech ecosystems in Denmark and Sweden

The trends that will shape the biotech industry in 2024

Eight companies spearheading Philadelphia’s biotech industry

Yumanity selling neurology assets and merging with Kineta

European Biotech’s Biggest News of 2018

Subscribe to our newsletter to get the latest biotech news!

Webinar: Organoids in cancer research - Paving the way for faster drug development across cancer indications

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Webinar: Organoids in cancer research - Paving the way for faster drug development across cancer indications

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!